Emergen Research, a leading provider of market research solutions, is thrilled to announce the release of its highly anticipated collection of comprehensive market research content. This innovative offering aims to empower businesses across industries with valuable insights and data-driven strategies to drive growth and success. 

In today's competitive marketplace, staying ahead of the curve is essential for businesses of all sizes. Understanding consumer behavior, market trends, and emerging opportunities is crucial for making informed decisions and developing effective strategies. Emergen Research recognizes this need and has invested significant resources in developing a cutting-edge market research content library. 

The newly launched Interoperability Solutions in Healthcare market research content is meticulously crafted by industry experts, leveraging extensive data analysis, and a deep understanding of various markets. This rich collection includes in-depth reports, whitepapers, case studies, trend analyses, and industry insights covering a wide range of sectors, including but not limited to technology, healthcare, finance, consumer goods, and manufacturing. 

The global Interoperability Solutions in Healthcare Market is estimated at USD 6.1 billion in 2025 and is projected to reach USD 17.4 billion by 2035, implying a CAGR of 11.5% over the forecast period.

This growth trajectory is structurally anchored in three high-impact forces:

1. Regulatory Mandates Driving Mandatory Data Exchange Infrastructure

Healthcare interoperability is no longer optional—it is being enforced through policy frameworks.

• The Centers for Medicare & Medicaid Services requires payers to implement patient access APIs and prior authorization data exchange standards, directly increasing demand for interoperability platforms.
• In Europe, the European Commission enacted the European Health Data Space (EHDS) framework in 2025, enabling standardized cross-border health data exchange.

Implication: Compliance-driven adoption ensures baseline, non-discretionary spending across providers, payers, and health systems.

1. Saturation of EHR Adoption Shifting Focus to Data Integration

Healthcare systems have largely digitized records—now the challenge is making them interoperable.

• The Office of the National Coordinator for Health Information Technology reports that ~96% of U.S. hospitals use certified EHR systems, indicating near-complete digitization.
• However, only ~70% of hospitals can fully integrate external patient data into workflows, highlighting a clear interoperability gap.

Implication: Spending is shifting from EHR deployment to integration engines, HIE platforms, and data normalization tools, expanding the addressable market.

1. Expansion of National and Cross-Border Health Data Networks

Governments are investing in infrastructure to enable large-scale, secure health data exchange.

• The Office of the National Coordinator for Health Information Technology introduced TEFCA (Trusted Exchange Framework and Common Agreement) to enable nationwide interoperability across healthcare entities.
• Public health reporting and real-world data usage have expanded significantly, requiring interoperable pipelines between hospitals, labs, and government systems.

Implication: Interoperability is evolving into a core healthcare infrastructure layer, not just a software feature.

Industry Validation Signals

• API-based healthcare ecosystems are scaling, driven by FHIR standards and payer-provider integration mandates.
• Public health data exchange requirements are increasing, especially post-pandemic.
• Healthcare IT budgets are reallocating toward interoperability layers, including data exchange, identity management, and consent frameworks.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Interoperability Solutions in Healthcare market evolving?
• What is driving and restraining the Interoperability Solutions in Healthcare market?
• How will each Interoperability Solutions in Healthcare submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each Interoperability Solutions in Healthcare submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading Interoperability Solutions in Healthcare markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Interoperability Solutions in Healthcare projects for these leading companies?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of Interoperability Solutions in Healthcare projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Interoperability Solutions in Healthcare market?
• Where is the Interoperability Solutions in Healthcare market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/15 

The global Interoperability Solutions in Healthcare Market is estimated at USD 6.1 billion in 2025 and is projected to reach USD 17.4 billion by 2035, implying a CAGR of 11.5% over the forecast period.

This growth trajectory is structurally anchored in three high-impact forces:

1. Regulatory Mandates Driving Mandatory Data Exchange Infrastructure

Healthcare interoperability is no longer optional—it is being enforced through policy frameworks.

• The Centers for Medicare & Medicaid Services requires payers to implement patient access APIs and prior authorization data exchange standards, directly increasing demand for interoperability platforms.
• In Europe, the European Commission enacted the European Health Data Space (EHDS) framework in 2025, enabling standardized cross-border health data exchange.

Implication: Compliance-driven adoption ensures baseline, non-discretionary spending across providers, payers, and health systems.

1. Saturation of EHR Adoption Shifting Focus to Data Integration

Healthcare systems have largely digitized records—now the challenge is making them interoperable.

• The Office of the National Coordinator for Health Information Technology reports that ~96% of U.S. hospitals use certified EHR systems, indicating near-complete digitization.
• However, only ~70% of hospitals can fully integrate external patient data into workflows, highlighting a clear interoperability gap.

Implication: Spending is shifting from EHR deployment to integration engines, HIE platforms, and data normalization tools, expanding the addressable market.

1. Expansion of National and Cross-Border Health Data Networks

Governments are investing in infrastructure to enable large-scale, secure health data exchange.

• The Office of the National Coordinator for Health Information Technology introduced TEFCA (Trusted Exchange Framework and Common Agreement) to enable nationwide interoperability across healthcare entities.
• Public health reporting and real-world data usage have expanded significantly, requiring interoperable pipelines between hospitals, labs, and government systems.

Implication: Interoperability is evolving into a core healthcare infrastructure layer, not just a software feature.

Industry Validation Signals

• API-based healthcare ecosystems are scaling, driven by FHIR standards and payer-provider integration mandates.
• Public health data exchange requirements are increasing, especially post-pandemic.
• Healthcare IT budgets are reallocating toward interoperability layers, including data exchange, identity management, and consent frameworks.

Competitive Landscape: 

The latest study provides an insightful analysis of the broad competitive landscape of the global Interoperability Solutions in Healthcare market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. 

Regulatory Enforcement of Interoperability Standards Accelerating Adoption

Government mandates are the single most decisive force converting interoperability from a strategic initiative into a compliance requirement.

• The Centers for Medicare & Medicaid Services mandates payer-to-payer data exchange and prior authorization APIs, forcing insurers and providers to implement standardized interoperability frameworks.
• The Office of the National Coordinator for Health Information Technology enforces FHIR-based interoperability under the 21st Century Cures Act, standardizing how health data is accessed and exchanged.

Why this driver exists:

Healthcare systems historically operated in siloed environments. Regulatory bodies are now mandating interoperability to:

• Improve patient data accessibility
• Reduce administrative burden
• Enable coordinated care delivery

Revenue impact:

• Mandatory upgrades to interoperability platforms
• Continuous compliance-driven spending (APIs, integration layers, data governance tools)
• Expansion of vendor ecosystems supporting FHIR and HL7 standards

Strategic implication:

• Investors: Regulatory-backed demand ensures predictable, non-cyclical revenue streams
• Companies: Early compliance and scalable interoperability architecture become competitive differentiators

Rise of Value-Based Care and Data-Driven Clinical Decision Making

Healthcare systems are shifting from volume-based to outcome-based care models, increasing reliance on interoperable data.

• The Centers for Medicare & Medicaid Services reports that over 50% of Medicare payments are now tied to value-based care models, requiring integrated patient data across care settings.
• Coordinated care models depend on seamless exchange of clinical, claims, and patient-generated data.

Why this driver exists:

Value-based care requires:

• Longitudinal patient records across providers
• Real-time data exchange for care coordination
• Integration of clinical and financial data

Revenue impact:

• Increased demand for interoperability platforms supporting analytics and population health management
• Growth in data aggregation, normalization, and exchange services
• Expansion of interoperability use cases beyond compliance into clinical workflows

Strategic implication:

• Investors: Platforms enabling real-time data integration will capture higher-value contracts
• Companies: Interoperability becomes central to care delivery models, not just IT infrastructure

Rapid Growth of Digital Health Ecosystems and Patient-Centric Applications

The proliferation of digital health tools is creating a fragmented data environment that requires interoperability solutions.

• The World Health Organization highlights that digital health adoption has accelerated globally, particularly in telemedicine, remote monitoring, and mobile health applications.
• Patient-facing apps, wearable devices, and telehealth platforms generate large volumes of health data that must integrate with clinical systems.

Why this driver exists:

• Expansion of remote care and decentralized healthcare delivery
• Increasing patient demand for access and control over personal health data
• Growth of third-party health applications requiring standardized APIs

Revenue impact:

• Increased demand for API management platforms and interoperability middleware
• Growth in patient data integration and consent management solutions
• Expansion of interoperability into consumer health ecosystems

Strategic implication:

• Investors: Companies enabling ecosystem-wide connectivity (providers, payers, apps) will see outsized growth
• Companies: Building interoperable platforms that integrate with digital health ecosystems is critical for long-term relevance

Emergen Research is Offering a full report (Grab a Copy Now) @ https://www.emergenresearch.com/industry-report/interoperability-solutions-in-healthcare-market

Market Segmentation: 

The report bifurcates the Interoperability Solutions in Healthcare market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. 

Key Companies Interoperability Solutions in Healthcare Market

• Oracle Health
• InterSystems
• athenahealth
• Rhapsody Health
• NextGen Healthcare
• Orion Health
• Veradigm
• Infor
• Health Catalyst
• eClinicalWorks

Key Company Analysis

• Oracle Health is strengthening its position by tying interoperability directly to national exchange infrastructure rather than limiting it to traditional interface connectivity. In 2025, Oracle Health moved from filing a TEFCA QHIN application in February to candidate status in May, and by November 2025 it announced full TEFCA QHIN designation. That progression matters strategically because it gives Oracle a stronger role in provider-payer-government exchange and makes its interoperability stack more valuable as a network access layer, not just an EHR add-on.
• InterSystems remains one of the most technically entrenched interoperability vendors because its business is built around health data integration infrastructure, especially through HealthShare Health Connect and IRIS for Health. The company’s 2025.3 general-availability release underscores continued investment in health-specific data-platform tooling, while its October 2025 collaboration with Google Cloud positioned HealthShare as a scalable real-time data foundation for AI-enabled workflows. That gives InterSystems an advantage with health systems that want interoperability, longitudinal records, and AI-readiness on the same architecture.
• athenahealth is differentiated by embedding interoperability into a cloud-native ambulatory platform rather than selling it only as middleware. In July 2025, the company said it had become the first healthcare IT company to implement TEFCA at scale, and in August 2025 it launched its AI-enabled intelligent interoperability positioning for physician practices nationwide. Strategically, that puts athenahealth in a strong position with mid-sized and community-based practices that want data exchange, payer/provider connectivity, and workflow automation without managing a fragmented stack of separate integration tools.
• Rhapsody Health continues to hold a strong share of the integration-engine layer, which remains one of the core software categories inside the interoperability market. In February 2025, Rhapsody said it won the Best in KLAS Integration Engine award for the 16th consecutive year, with Corepoint Integration ranked first in the category. It then expanded into API governance with the October 2025 launch of API Guardian, aimed at secure API exposure and AI-ready data exchange. That combination is important commercially because it shows Rhapsody is defending its legacy integration-engine base while expanding into the FHIR- and API-led architecture that newer interoperability buying cycles increasingly require.
• NextGen Healthcare is leaning into compliance-led interoperability and ambulatory network connectivity. In August 2025, it announced HTI-1 compliance for NextGen Enterprise EHR ahead of ONC’s deadline, and in September 2025 it partnered with Kno2 to expand nationwide interoperability for 100,000+ providers. That strategy is commercially relevant because it ties regulatory readiness to network expansion, helping NextGen compete on both standards compliance and practical data-exchange reach across specialty practices.

Strategic Takeaway

The market is led by two broad groups: enterprise platform vendors such as Oracle Health, InterSystems, and athenahealth that integrate interoperability into wider clinical and administrative ecosystems, and specialized interoperability players such as Rhapsody and Orion Health that compete more directly on exchange infrastructure, data movement, and integration performance. The likely winners are those that can combine FHIR/API readiness, TEFCA or national-network connectivity, workflow integration, and AI-ready longitudinal data architecture rather than offering standalone interface tools alone.

Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives. 

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/15 

Target Audience of the Global Interoperability Solutions in Healthcare Market Report: 

• Key Market Players 

• Investors 

• Venture capitalists 

• Small- and medium-sized and large enterprises 

• Third-party knowledge providers 

• Value-Added Resellers (VARs) 

• Global market producers, distributors, traders, and suppliers 

• Research organizations, consulting companies, and various alliances interested in this sector 

• Government bodies, independent regulatory authorities, and policymakers 

About Emergen Research  

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. 

Contact Us: 

Eric Lee 

Corporate Sales Specialist 

Emergen Research | Web: https://www.emergenresearch.com/ 

Direct Line: +1 (604) 757-9756 

E-mail: sales@emergenresearch.com